Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed a Form 8-K Current Report on January 28, 2020. The filing reports the approval and implementation of a reverse stock split of the Company's common stock.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company executed a 1-for-150 reverse stock split of its common stock.
- Effective Date: The split became effective with FINRA and in the marketplace at the open of business on February 3, 2020.
- Trading Symbol: The symbol changed to "CELZD" for 20 business days starting February 3, 2020, before reverting to "CELZ".
- CUSIP Number: The CUSIP number changed to 22529Y 200.
- Share Adjustment: Share counts were divided by 150 and rounded up to the next whole number. No fractional shares or cash payments were issued.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The primary purpose is to notify the market of the amendment to the Articles of Incorporation regarding the stock split. Stockholders' percentage ownership and voting power remain unchanged, subject to minor rounding adjustments.
Investor Verification Checklist
- Verify the new trading symbol "CELZD" and subsequent reversion to "CELZ" on brokerage platforms.
- Confirm the updated CUSIP number (22529Y 200) for trade settlement.
- Check account statements to ensure share counts were adjusted by the 1-for-150 ratio with proper rounding.
- Review the Certificate of Amendment (Exhibit 3.1) for specific legal terms of the split.